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Potential Role of the
Ubiquitin-Proteasome System in Atherosclerosis
Aspects of a Protein Quality Disease
Joerg Herrmann, MD, Sandra M. Soares, MD, Lilach O. Lerman, MD, PHD, Amir Lerman, MD
Rochester, Minnesota
Misfolded or damaged proteins are recognized intracellularly by protein quality mechanisms. These include
chaperones and the ubiquitin-proteasome system, which aim at restoration of protein function and protein re-
moval, respectively. A number of studies have outlined the functional significance of the ubiquitin-proteasome
system for the heart and, as of recently, for the vascular system. This review summarizes these recent findings
with a focus on atherosclerosis. In particular, this paper reflects on the viewpoint of atherosclerosis as a protein
quality disease. (J Am Coll Cardiol 2008;51:2003–10) © 2008 by the American College of Cardiology
Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2008.02.047p
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Fhe structure and function of cells and related organs,
ncluding the cardiovascular system, is determined to a
ignificant degree by the structure and function of their
roteins. The synthesis of new proteins is balanced by the
egradation of those that have become disposable for
arious reasons. Recent research findings have highlighted
he significance of these biological processes for cardiovas-
ular diseases. The present review will summarize these
dvances, introducing the viewpoint of atherosclerosis as a
rotein quality disease.
rotein Quality Mechanisms
he quality of a protein and its function relies on its
-dimensional structure and folding dynamics. The loss of
roper 3-dimensional arrangement, referred to as unfolding,
mpairs not only protein function but eventually also cellular
unction and viability. To prevent these detrimental conse-
uences, each cell is equipped with 2 operational systems:
haperones and proteases.
Chaperones recognize protein substrates based on hydro-
hobic protein regions, which are usually buried within the
ertiary and quarternary structures but surface as the protein
tructure unfolds after translational or post-translational
amage. Variations in the protein sequences that flank these
ydrophobic sequences determine the large number and
arious types of chaperones across the different cellular
ompartments (1). Their main function is to hold misfolded
rom the Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.
upported by the National Institutes of Health (R01 HL63911-04, K24 HL69840-
1), the Mayo Stiftung, and the Mayo Foundation.a
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008, accepted February 12, 2008.roteins, to fold them back into their native structure, and
o promote the degradation of proteins resistant to this
rocess by making them more accessible to proteases. This
atter group of enzymes cleaves proteins based on amino
cid sequence patterns. Up to 90% of all intracellular
roteins are degraded, both in a chaperone-dependent and
n a chaperone-independent manner, by a specialized pro-
ease system, called the ubiquitin-proteasome system (UPS)
2). This system operates mainly in the cytoplasm and
ecognizes protein substrates, like chaperones, on the basis
f bulky hydrophobic residues but also based on basic
esidues at the NH2-terminus (so-called N-end rule). Thus,
umerous chaperones and the UPS work independently and
n synergy to assure the quality of intracellular proteins.
The kinetics of the interactions between chaperones, the
PS, and damaged proteins were summarized in a triage
odel (Fig. 1) (3). One particular subtype of protein quality
ontrol mechanisms is the unfolded protein response (4).
his response is triggered by the accumulation of unfolded
r misfolded proteins in the lumen of the endoplasmic
eticulum (ER), which is also referred to as ER stress and
eads to the modification of transducer proteins in the ER
embrane and the activation of their related pathways.
hese pathways include the inositol-requiring protein 1, the
ctivating transcription factor-6, and the protein kinase
ibonucleic acid-like kinase signaling pathways. Collec-
ively, these pathways orchestrate the down-regulation of
he synthesis and the translocation of proteins into the ER,
hich leads to a reduction in protein load. They also
ediate the expression of chaperones and protein-
odifying enzymes, which facilitates protein refolding.
urthermore, they engage the endoplasmic reticulum-
ssociated protein degradation pathway, which entails the
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Protein Quality and Atherosclerosis May 27, 2008:2003–10retrotranslocation of unfolded
proteins into the cytosol and
their proteolysis by the protea-
some. In case these mechanisms
fail to resolve the mismatch be-
tween protein load and handling
capacity over a period of time,
the unfolded protein response in-
duces autophagy as an alternative
coping mechanism. This process
involves the sequestration of the
ER into membrane-bounded
compartments (autophagosomes),
its fusion with lysosomes, and the
degradation of its content. The
ER-specific autophagy is seem-
ingly essential for cells to survive
severe ER stress (5). However,
with overwhelming ER stress cell
death pathways are nevertheless
activated.
In summary, cells are equipped with a robust apparatus to
epair or remove damaged proteins. This includes chaperones,
roteases, and the ER-related unfolded protein response along
he general concept of protein triaging. The competitive
alance between the activity of protein quality control mech-
Abbreviations
and Acronyms
Abeta  amyloid beta
protein
APP  amyloid precursor
protein
ER  endoplasmic
reticulum
ERAD  endoplasmic
reticulum-associated
protein degradation
HSP  heat shock protein
LDL  low-density
lipoprotein
ROS  reactive oxygen
species
TIA  transient ischemic
attack
UPS  ubiquitin-
proteasome system
Figure 1 Protein Triage System
Because of translational or post-translational damage, proteins can become misfo
tion sites for chaperones, which aim at restoring the native protein structure or tri
aged proteins directly and mediates the attachment of at least 4 ubiquitin molecu
enzymes can reverse the ubiquitin-chain degradation signal, and damaged proteins
teins, can be recognized directly by the proteasome complex. A protein’s propensi
chaperones versus proteases, will determine its fate. This includes restoration of
aggregation.nisms, on the one hand, and the generation of low-quality
roteins, on the other hand, is the hallmark of this concept.
rotein Quality Diseases
rotein quality diseases, also called protein misfolding,
recipitation, or conformational diseases, are a group of
isorders that are associated with and occasionally caused by
he conformational change, aggregation, and deposition of 1
r more proteins (6). Neurodegenerative diseases were the
rst prominent example for this entity. Mutation analyses in
amilial counterparts to sporadic neurologic disorders and
xperimental studies highlighted the pathogenetic role of
he accumulation of misfolded proteins in these disease
rocesses (7,8). Research efforts also showed that the
ccumulation of these proteins is due to their increased
roduction, abnormal processing, and/or decreased elimina-
ion via chaperones, the UPS, or the unfolded protein
esponse (8,9). The “amyloid hypothesis” of neurodegenera-
ive diseases links the aggregation of misfolded proteins into
rdered protease-resistant structures, called amyloid fibrils,
o aberrant protein interactions that culminate in neuronal
ysfunction and ultimately neurodegeneration (10). Indeed,
he pathological momentum seems to be with the very
rocess of amyloid formation.
eading to surface exposure of hydrophobic regions. These regions are recogni-
the ubiquitin-proteasome system (UPS). This system can also recognize dam-
ich directs proteins to degradation by the proteasome. Deubiquitinating
ve a new chance for refolding. Some proteins, such as oxidatively damaged pro-
ld to a state with particular binding characteristics, including the affinity for
structure and function, protein degradation, and protein cross-linking andlded, l
age to
les, wh
recei
ty to fo
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May 27, 2008:2003–10 Protein Quality and AtherosclerosisAmyloid formation is an ordered process and begins
hen misfolded proteins start to assume a beta-pleated
heet structure and self-associate to form soluble pre-
myloid oligomers. As these soluble preamyloid oligomers
tart to form protofibrils and coalesce, classic amyloid fibrils,
laques, and tangles are formed, which then exhibit Congo
ed-positive staining. Classic amyloid plaques are therefore
late and final reflection of a process that remains unde-
ected in its peak toxicity. Consistent with this view,
eurologic disease precedes the histologic appearance of
lassic amyloid plaques. As another implication, the focus of
ttention has shifted from the large aggregates and micro-
copic hallmarks to the small aggregates and molecular
rocesses of the pre-amyloid stage both extracellularly and
ntracellularly (11). Moreover, there has been the realization
hat the process of aggregation is not inherent to only a few
roteins but can be observed with various proteins once
isfolding remains unresolved (12).
In summary, unfolded/misfolded proteins can accumulate in
ells and tissues when they are produced in large amounts
nd/or not cleared sufficiently. These proteins then form
ggregates, which can remove amino acids from the recycling
ool, tie up chaperones and proteases, serve as foci for the
ggregation of other unrelated proteins, and finally disrupt
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Figure 2 Chaperone Expression in Early and Advanced Experim
Aortic samples from apolipoprotein E/ mice fed a Western diet for up to 40 wee
increase in the expression of heat shock protein (HSP) 60 and HSP70 by immuno
confirms these findings and shows that this increase in expression is specific for
sion of the American Heart Association (16).ellular and tissue functions. Over time, the accumulation of
ow-quality proteins can therefore result in disease, a so-called
rotein quality disease. Precipitates such as amyloid are char-
cteristic late-stage histologic fingerprints.
rotein Quality Control in Atherosclerosis
esides inflammation, excess generation of reactive oxygen
pecies (ROS), so-called oxidative stress, is considered to be
n important element in the pathophysiology of atheroscle-
osis (13). Among the various effects, oxidative stress has
een shown to increase the expression of chaperones,
ncluding those of the family of heat shock proteins (HSPs).
he HSPs most closely associated with atherosclerosis
nclude HSP60 and HSP70. The expression of HSP60 in
he vascular wall correlates with the severity of atheroscle-
osis and is particularly prominent in the shoulder regions
nd around necrotic cores of atherosclerotic plaques (14).
he HSP70 is mainly expressed in more advanced athero-
as around sites of necrosis and lipid accumulation (15).
mportantly, these findings can be reproduced experimen-
ally in hypercholesterolemic apolipoprotein E/ mice, in
hich the expression of both HSPs increases in the early
nd progressive disease stages (Fig. 2) (16).
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d a chow diet for 69 weeks. As presented in the upper panels, there is an
emistry from 3 to 20 weeks. Immunoblotting, as presented in the lower panels,
sites and decreases in chronic lesions of aged mice. Images used with permis-sure
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Protein Quality and Atherosclerosis May 27, 2008:2003–10There is also evidence for stimulation of the UPS in
therosclerosis. Coronary artery plaques associated with
atal acute myocardial infarction are characterized by
ncreased expression of ubiquitin/ubiquitinated proteins,
specially in the shoulder and cap regions (Fig. 3) (17).
imilarly, carotid artery plaques from patients with symp-
oms of focal cerebral ischemia display a higher level of
biquitinated proteins than those obtained from asymp-
omatic patients (Fig. 3) (18,19). In experimental models
f atherosclerosis, we and others demonstrated that levels
f ubiquitinated proteins start to increase at early disease
tages (20,21). Furthermore, there is evidence of a
oncomitant increase in proteasome activity in experi-
ental hypercholesterolemia and hyperglycemia, proba-
ly to compensate for the increased amount of substrates
or the system, including misfolded proteins, under those
Figure 3 Ubiquitin Expression and Proteasome Activity in Adva
Increase in ubiquitin immunoreactivity in complicated plaques of fatal acute myoca
farction-related coronary arteries of the same patient, relating to differences in the
graph adapted, with permission, from Herrmann et al. (17). In carotid artery plaqu
(Am.) fugax, the level of ubiquitin-protein conjugates, but not of free ubiquitin, is h
patients (right). Graphs on the right used with permission of the American Heart Aircumstances (21–23). fiAlong these lines, activation of the unfolded protein
esponse has been reported as a very early phenomenon in
therosclerosis (24). Cholesterol accumulation and oxidative
tress products such as peroxynitrite seem to be the most
otent inducers for the unfolded protein response in mac-
ophages and endothelial cells, respectively (25–27). In
hese cells, activation of the unfolded protein response has
een linked to cytotoxicity but might not be sufficient to
rigger cell death by itself (24,28). How the unfolded
rotein response directs to life or death of a cell is currently
ncompletely understood. Nevertheless, there is consistency
n the view that cell death pathways are activated under
ircumstances of unmitigated or overwhelming ER stress.
Taken together, there is up-regulation of the expression and
ctivity of chaperones, the UPS, and the unfolded protein
esponse with overlapping features in atherosclerosis. These
Atherosclerosis
nfarction-related coronary arteries compared with advanced plaques in the nonin-
lder and fibrous cap areas (left). Images on the left and data for the bottom left
atients with symptoms of transient ischemic attack (TIA), stroke, or amaurosis
nd proteasome function is lower than in carotid plaques from asymptomatic
tion (19).nced
rdial i
shou
es of p
igher a
ssociandings point to an increased demand of protein quality
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May 27, 2008:2003–10 Protein Quality and Atherosclerosisechanisms to prevent the vascular accumulation of misfolded
roteins increasingly generated by oxidative stress and other
actors. The compensatory efforts might be successful in the
eginning but might not suffice over a long period of time.
rotein Quality Disease
spects of Atherosclerosis
utopsy-based studies highlighted lower-level expression of
SPs in complicated, acellular, and collagenous plaques in
oth human disease and experimental models (15,29). Fur-
hermore, in hypercholesterolemic apolipoprotein E-deficient
ice, HSP expression decreases in the more advanced plaques
efore the development of complications (Fig. 2) (16). These
ndings indicate that chaperone function may become rela-
ively insufficient in the aged and advanced disease stages.
Although the activity of the ubiquitin system remains
eemingly unimpaired even in advanced atherosclerotic
laques, increase as well as decrease in proteasome activity
as been observed in symptomatic carotid artery plaques
18,19). In a large animal model, we have recently demon-
trated that chronic inhibition of the proteasome contrib-
tes to endogenous oxidative stress and atherogenesis (22).
n contrast, other groups have noted that in vivo or ex vivo
roteasome inhibition for a relatively short period of time
ields beneficial vascular effects (23,30,31). The complexity
nd diversity of the data is recaptured in the in vitro finding
hat high concentrations of oxidized low-density lipoprotein
LDL) lead to an initial transient activation of proteasome
unction followed by a sustained decay of proteasome
ctivity and that proteasome inhibition potentiates the
ytotoxic effects of oxidized LDL (32). Intensity and dura-
ion of the modulation of proteasome function and its
pecific environment are seemingly key variables for a
umber of biological processes, and their interaction deter-
ines the ultimate consequences for cells and tissues.
If protein quality mechanisms decreased in their activity over
ime, one would expect accumulation and aggregation of
isfolded proteins in “aged” arteries. If causally related to
therogenesis, these changes might also be particularly prom-
nent in atherosclerotic lesions. As recently shown in experi-
ental hypercholesterolemia, oxidatively modified and ubiqui-
inated proteins accumulate in the vascular wall, especially with
nhibition of the compensatory increase in proteasome activity
22). Under those circumstances, prominent intimal thickening
an be observed as well (22). With progression of disease,
eposition of amyloid can be found in the intima adjacent to
therosclerotic plaques in up to one-half of the cases and to a
imilar extent within the plaque area, mainly in the necrotic
ore regions (Fig. 4) (33,34). Accumulation of intracellular
roteins, modified by oxidation, nitration, phosphorylation, or
as particularly prominent in diabetes) glycylation, may repre-
ent part of the amyloidogenic burden. Apolipoproteins con-
titute the most important extracellular source for amyloid
brils in atherosclerotic plaques. This relates to mutations as
ell as their limited conformational stability in the absence of Iipids, which can result from enzymatic or oxidative particle
odification, dissociation, or displacement (35,36). Further-
ore, members of the cathepsin family of proteases may cleave
polipoproteins to generate amyloid-prone fragments (37).
polipoprotein amyloidosis may therefore be simply a reflec-
ion of lipoprotein metabolism. However, fibrillar amyloid-like
roteins have been shown to stimulate CD36 signaling in
therosclerotic plaques, thereby assuming a more active role in
issue inflammation and ROS production (38). Finally, the
oad of amyloidogenic particles in atherosclerotic plaques
ight be increased by platelet-derived and locally expressed
myloid precursor protein (APP), which has been linked to a
umber of vascular changes.
The APP processing leads to formation of amyloid beta
rotein (Abeta), causally related to Alzheimer’s disease.
Figure 4 Amyloid Staining in
Advanced Human Atherosclerosis
Advanced human atherosclerotic plaques in the aorta reacting with antiserum
to apolipoprotein A-1 (A and C) (bar  50 m) in colocalization with amyloid,
which was visualized as green birefringence by Congo red staining (B and D).
Images used with permission of John Wiley & Sons (33). Hematoxylin-eosin
staining of an advanced carotid atherosclerotic plaque (E), exhibiting green
birefringence by Congo red staining as an indicator of amyloid deposition in
areas near the shoulder (F) and the lipid core (G) in the absence of primary
amyloidosis (original magnifications: E: 2; F, G: 5).ntriguingly, overexpression of a mutant form of APP in
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Protein Quality and Atherosclerosis May 27, 2008:2003–10ice (Tg-APP23) leads to progressive flow abnormalities
ithin the cerebral circulation on magnetic resonance an-
iography, relating to vessel constriction, deformation, and
losure (Fig. 5) (39). Moreover, impairment of endothelium-
ependent vasorelaxation of carotid arteries and the aorta can
e found in related mice (Tg2576) and is attenuated by
ndothelin-receptor antagonism (40). Likewise in a mouse
odel, systemic infusion of soluble Abeta leads to an increase
n vascular resistance and a decrease in cerebral perfusion
41). These findings correspond to the provasoconstricting/
ntivasorelaxing properties of Abeta, which were docu-
ented in in vitro studies and ultimately attributed to
beta-induced inhibitory signaling on endothelial nitric
xide synthase activity (42). Of further note, histologic
tudies confirm the capacity of Abeta to cause structural
amage of endothelial cells and to induce tissue inflamma-
ion (43,44). Intracellular accumulation of Abeta can also
ead to mitochondrial dysfunction, with release of free
adicals and its important implications (11). It can also
mpair proteasome function, resulting in further Abeta
ccumulation (11). As amyloid deposition progresses, so do
he degenerative changes of the vascular wall. These include
neurysmal dilation, vascular rupture, and hemorrhage on
Figure 5 Vascular Changes Due to Overexpression of Mutant A
Compared with normal cerebral vascular anatomy and flow dynamics in 10-month-old
old mice overexpressing a mutant form of amyloid precursor protein (APP23) with fairl
cant flow abnormalities, including partial and complete flow voids (C). The correspond
noteworthy is the presence of a small artery connecting the left and the right sides of
under the circumstance of vessel substitution at the posterior cerebral artery level. Imhe one end and narrowing and occlusion of vessels on the sther end of the spectrum. In its entirety, this vascular
rocess has become known as cerebral amyloid angiopathy
nd is frequently seen in patients with Alzheimer’s disease
45). In fact, the neuropsychologic deficits of Alzheimer’s
isease seem to correlate better with the degree of amyloid
eposition in the cerebral vessels than in the brain. Last
ut not least, learning disabilities and cerebral Abeta de-
osits are greater in atherosclerosis-susceptible APP-
verexpressing Tg2576 mice fed an atherogenic diet, and the
xtent of aortic atherosclerosis is enhanced by the APP-
ransgenic trait and correlates with the cerebral Abeta burden
n these mice (46).
In summary, nonfibrillar and fibrillar forms of the classic
myloidogenic protein Abeta have been shown to cause
ndothelial injury and dysfunction as well as progressive
tructural changes of the entire vascular wall in the context
f cerebral amyloid angiopathy over time. Similar degener-
tive changes can be observed in atherosclerosis, and syner-
ism has been suggested in the pathophysiology of Alzhei-
er’s disease and atherosclerosis. Within the framework of
rotein quality diseases, the accumulation of damaged
ntracellular proteins and the deposition of amyloidogenic
xtracellular proteins may be of significance for the athero-
id Precursor Protein
ce (A), magnetic resonance angiography shows minor flow voids (arrow) in 6-month-
rved structures on corrosion casts (B). Twenty-month-old APP23 mice display signifi-
rosion cast demonstrates constriction, inclusions, and vessel elimination (D). Also
cle of Willis (# in panels C and D) likely to maintain a dimunitive level of blood flow
sed with permission of the Society of Neuroscience (39).mylo
wild mi
y prese
ing cor
the cir
ages uclerotic disease process (Fig. 6).
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ertainly, one of the central remaining questions is
hether the accumulation of dysfunctional proteins is a
ausal factor, a contributing factor, or simply an epiphe-
omenon in atherosclerosis, similar to the current dis-
ussion in heart failure (47,48). Mice expressing an
nchorless prion protein that is insoluble and resistant to
roteolysis develop cardiomyopathy, which constitutes
he strongest experimental evidence so far for the detri-
ental consequences of protein precipitation on cardiac
unction (49). Intriguingly, in this model, amyloid dep-
sition can be seen primarily within and around endo-
helial cells (49,50). Further studies on the vasofunctional
nd vasostructural consequences of these findings would
e very helpful in attesting that protein precipitation by
tself exerts a pathophysiological and notably atherogenic
omentum. Positive results would prompt further stud-
es on how proteins can escape protein quality control
echanisms and perturb vascular homeostasis in the
uman vasculature. These studies should be comple-
Figure 6 Illustration of Atherosclerosis as a Protein Quality Dis
In the initial phase of cardiovascular risk factor exposure, compensatory up-regula
whelming intracellular accumulation of damaged and dysfunctional proteins. The U
kappa-B and thereby to inflammation and cell proliferation. With the formation and
misfolded and damaged proteins in the progression phase. Once the classical pro
mulate (and aggregate) and autophagy remains the final clearance pathway. The a
As yet another unique characteristic, beta-pleated sheets can be formed and henc
In addition to intracellular proteins, proteins in the extracellular matrix can undergo
density lipoprotein (LDL) produces oxidatively modified and electronegative particle
with permission of Elsevier Science [35]). The generation of amyloid-like structures
macrophages via scavenger receptors (37). Recognition of amyloid-like fibrils by CD
production of reactive oxygen species, chemokines, and cytokines, which contribuented by gain-of-function and loss-of-function studiesn central components of the 2 arms of the protein
uality control system. Clinical studies evaluating the effect
f selective positive or negative modulation of the systems in
elation to the stage of disease will give final answers from
human disease and therapy standpoint. With this perspec-
ive, the viewpoint of atherosclerosis as a protein quality
isease may contribute to current theory and future treat-
ent of atherosclerotic cardiovascular disease.
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